{"sourcedb":"DevicePMAs@therightstef","sourceid":"P060034_S004","text":"Approval for expanding the intended use to include use with the evolisautomated microplate system. the device, as modified, will be marketed under the trade namemonolisa anti-hbc igm eia and is indicated for use in the qualitative detection of igmantibodies to hepatitis b core antigen (anti-hbc igm) in human serum or plasma (potassiumedta, sodium citrate, acd [acid citrate dextrose], lithium heparin and sodium heparin). assay results may be used with other hbv serological markers for the laboratory diagnosis of hbv disease associated with hbv infection. the monolisa anti-hbc igm is intended formanual use and with the bio-rad evolis automated microplate system in the detection ofigm antibodies to hepatitis b virus.","project":"consensus_PMA_Age_Indications"}